By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Italian firm A. Menarini Diagnostics will exclusively distribute Transgenomic's Surveyor Scan and Wave Micro-capillary electrophoresis (MCE) mutation detection system throughout Europe as part of a deal announced today.

Under the terms of the deal, Menarini, based in Florence, Italy, will make the Transgenomic technology available to the more than 2,000 pathologists in its European network. Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.